Creo Medical Group (CREO) Competitors GBX 11.25 0.00 (0.00%) As of 11:57 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock CREO vs. EKF, IUG, NCYT, IHC, AVO, RUA, SUN, MHC, POLX, and BELLShould you be buying Creo Medical Group stock or one of its competitors? The main competitors of Creo Medical Group include EKF Diagnostics (EKF), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), MyHealthChecked (MHC), Polarean Imaging (POLX), and Belluscura (BELL). These companies are all part of the "medical devices" industry. Creo Medical Group vs. Its Competitors EKF Diagnostics Intelligent Ultrasound Group Novacyt Inspiration Healthcare Group Advanced Oncotherapy RUA Life Sciences Surgical Innovations Group MyHealthChecked Polarean Imaging Belluscura EKF Diagnostics (LON:EKF) and Creo Medical Group (LON:CREO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations. Does the media refer more to EKF or CREO? In the previous week, Creo Medical Group's average media sentiment score of 0.00 beat EKF Diagnostics' score of -0.64 indicating that Creo Medical Group is being referred to more favorably in the news media. Company Overall Sentiment EKF Diagnostics Negative Creo Medical Group Neutral Which has more volatility and risk, EKF or CREO? EKF Diagnostics has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Comparatively, Creo Medical Group has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Which has higher valuation & earnings, EKF or CREO? EKF Diagnostics has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEKF Diagnostics£50.22M2.54£4.68M£0.012,100.07Creo Medical Group£4.60M10.09-£25.04M-£0.01-1,125.00 Do insiders and institutionals believe in EKF or CREO? 50.0% of EKF Diagnostics shares are owned by institutional investors. Comparatively, 45.1% of Creo Medical Group shares are owned by institutional investors. 39.4% of EKF Diagnostics shares are owned by company insiders. Comparatively, 4.1% of Creo Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is EKF or CREO more profitable? EKF Diagnostics has a net margin of 9.37% compared to Creo Medical Group's net margin of -73.93%. EKF Diagnostics' return on equity of 7.03% beat Creo Medical Group's return on equity.Company Net Margins Return on Equity Return on Assets EKF Diagnostics9.37% 7.03% 5.27% Creo Medical Group -73.93%-41.79%-20.09% SummaryEKF Diagnostics beats Creo Medical Group on 9 of the 12 factors compared between the two stocks. Get Creo Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CREO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CREO vs. The Competition Export to ExcelMetricCreo Medical GroupMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£46.40M£2.53B£6.05B£2.60BDividend YieldN/A2.44%5.73%5.30%P/E Ratio-1,125.00198.0585.974,396.31Price / Sales10.09134.92582.52100,736.12Price / Cash2.4315.9925.7327.90Price / Book0.863.9012.688.07Net Income-£25.04M£132.05M£3.31B£5.89B7 Day Performance-5.30%-1.48%-0.43%-0.11%1 Month Performance-6.25%2.56%8.68%2.21%1 Year Performance-49.44%18.15%76.47%145.00% Creo Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CREOCreo Medical GroupN/AGBX 11.25flatN/A-49.4%£46.40M£4.60M-1,125.00279EKFEKF DiagnosticsN/AGBX 29.40-5.2%N/A-5.4%£132.03M£50.22M2,177.78356Gap DownIUGIntelligent Ultrasound GroupN/AN/AN/AN/A£42.76M£6.57M-18.9165NCYTNovacytN/AGBX 39.71-3.4%N/A-25.4%£28.05M£19.45M-67.31120IHCInspiration Healthcare GroupN/AGBX 20-7.0%N/A+18.0%£17.93M£38.25M-106.27224Earnings ReportAVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11.55+0.4%N/A-25.4%£7.17M£4.11M-2.6148High Trading VolumeSUNSurgical Innovations GroupN/AGBX 0.60+4.2%N/A-0.2%£5.59M£11.92M-383.9780Gap UpMHCMyHealthCheckedN/AGBX 9-14.3%N/A-28.9%£5.46M£3.22M-239.3616Gap DownPOLXPolarean ImagingN/AGBX 0.44-2.7%N/A-66.0%£5.29M£2.56M-438.0028Gap DownHigh Trading VolumeBELLBelluscuraN/AGBX 0.75flatN/AN/A£3.01M£1.80M-5.7324 Related Companies and Tools Related Companies EKF Diagnostics Competitors Intelligent Ultrasound Group Competitors Novacyt Competitors Inspiration Healthcare Group Competitors Advanced Oncotherapy Competitors RUA Life Sciences Competitors Surgical Innovations Group Competitors MyHealthChecked Competitors Polarean Imaging Competitors Belluscura Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CREO) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creo Medical Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Creo Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
